
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage, for any covered stock.
TapClick below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
TapClick below to see what's inside, then upgrade to unlock for HLI and 80,000+ other tickers.
See price against where its own fundamentals say it should trade. The shaded gap is the discount or premium, across five valuation lenses.
TapClick below to see what's inside, then upgrade to unlock for HLI and 80,000+ other tickers.
See exactly how HLI's revenue becomes profit: a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for HLI and 80,000+ other tickers.
Houlihan Lokey, Inc. is a prominent global investment banking firm offering a comprehensive suite of financial advisory services. These include expertise in mergers and acquisitions (M&A), capital markets, financial restructuring, and valuation. The company's operations are divided into three core segments: The Corporate Finance division provides broad financial guidance. It assists both public and private entities with strategic buy-side and sell-side transactions and a variety of capital-raising activities, such as leveraged loans, private mezzanine debt, high-yield debt, initial public…

Houlihan Lokey remains a leading diversified financial advisory firm, with a strong franchise and tenured management team. HLI's Corporate Finance segment faces temporary headwinds, but record backlog and stable transaction activity suggest underlying demand remains resilient. Revenue per transaction is declining in Corporate Finance, while Financial Restructuring and Valuation Advisory offer meaningful diversification benefits.

Houlihan Lokey is uniquely positioned as a top-tier restructuring advisor amid a looming debt crisis, with a best-in-class track record in major bankruptcies. HLI's share price has lagged due to heavy exposure to mid-market M&A, but the market underestimates the counter-cyclical potential of its restructuring business. AI sector debt issuance has surged, creating significant restructuring opportunities; HLI's expertise and deal flow in technology position it to benefit from sector distress.

Houlihan Lokey (HLI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Brookfield (NYSE: BN - Get Free Report) and Houlihan Lokey (NYSE: HLI - Get Free Report) are both finance companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, profitability, analyst recommendations, earnings, valuation and risk. Dividends Brookfield pays an annual dividend of $0.28 per

LOS ANGELES--(BUSINESS WIRE)--Houlihan Lokey, Inc. (NYSE:HLI), the global investment bank, today announced that it will release its second quarter results for the 2027 fiscal year on Wednesday, October 28, 2026, after the close of trading on the New York Stock Exchange. Houlihan Lokey will host a conference call at 5:00 p.m. (ET) that same day to review the results. On the call, Scott Adelson, Chief Executive Officer, and Lindsey Alley, Chief Financial Officer, will discuss the fiscal 2027 seco.